Mizuho analyst Steven Valiquette raised the firm’s price target on Cardinal Health (CAH) to $210 from $170 and keeps an Outperform rating on the shares. With greater momentum following the company’s fiscal Q1 report and the Solaris deal, the firm raised its FY26 EPS estimate to $9.80 from $9.40 and its FY27 estimate to $11.20 from $10.60, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health price target raised to $220 from $190 at Jefferies
- Cencora price target raised to $345 from $315 at BofA
- McKesson price target raised to $900 from $850 at BofA
- Cardinal Health price target raised to $225 from $183 at TD Cowen
- Cardinal Health Reports Strong Earnings and Raises Guidance